The previously communicated release date was
For additional information, please contact:
Jakob Dynnes Hansen, CFO,
Telefon: +45 5132 3698
E-post: jakob.dynnes@asarinapharma.com
The Company’s Certified Adviser is
© Modular Finance, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.676 SEK | -8.15% |
|
-10.58% | -23.18% |
Feb. 27 | Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Asarina Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
The previously communicated release date was
For additional information, please contact:
Jakob Dynnes Hansen, CFO,
Telefon: +45 5132 3698
E-post: jakob.dynnes@asarinapharma.com
The Company’s Certified Adviser is
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-23.18% | 1.57M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.08% | 26.22B | |
-25.37% | 19.01B | |
-19.70% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |